Yes, it was. Listen to the call once more. My guess is that expectations for Adderall ER are pretty low if we can buy it with cash we’ll have on hand by this time next year while continuing to fund R&D.
"And the last question, when will you -- when will we acquire markers right to half of the Amphetamine IR and ER ANDAs?
When we have or can raise sufficient cash to do so. We know exactly how much we need. When we have it, the product is available. My personal guess it will probably happen in mid-2022."